期刊文献+

DLC1和RhoA表达对乳腺癌淋巴道转移的影响 被引量:1

The effect of DLC1 and RhoA in lymphatic metastasis of breast cancer
下载PDF
导出
摘要 目的探究肝癌缺失基因1(DLC1)与RhoA表达对乳腺癌淋巴道转移的影响。方法收集已发生淋巴结转移的乳腺癌病变组织标本25例,未发生淋巴结转移的乳腺癌病变组织标本30例,采用免疫组化(SP)法检测DLC1与RhoA在两组标本中的表达情况,应用统计学方法对实验结果进行分析。结果在发生转移和未发生转移的乳腺癌病变组织中DLC1阳性率分别为44.00%和73.33%(χ2=4.889,P=0.027),RhoA阳性率分别为92.00%和50.00%(χ2=11.264,P=0.001),spearman等级相关分析显示DLC1与RhoA在乳腺癌病变组织中的表达呈负相关(r=-0.454,P=0.000)。结论乳腺癌淋巴道转移与DLC1低表达、RhoA高表达密切相关。 Objective Through detect the expression of DLC1 and RhoA protein in breast cancer tissues,investigate the effect of DLC1 and RhoA in lymphatic metastasis of breast cancer.Methods Totally 25 breast cancer specimens that had occurred lymph node metastasis and 30 breast cancer specimens that had not occurred lymph node metastasis were collected,the expression of DLC1 and RhoA were tested by immunochemistry,and the experimental data were analyzed by statistical methods.Results The positive rate of DLC1 in the breast cancer specimens that had occurred lymph node metastasis was 44.00%,that had not occurred lymph node metastasis was 73.33%(χ2=4.889,P=0.027),and the positive rates of RhoA in the two specimens were 92.00%and 50.00%(χ2=11.264,P=0.001).Spearman rank correlation analysis showed the expression of DLC1 and RhoA had a negative correlation in breast cancer tissues(r=-0.454,P=0.000).Conclusion The breast cancer lymphatic metastasis and is closely related to the low expression of DLC1 and the high expression of RhoA.
出处 《重庆医学》 CAS 北大核心 2015年第32期4519-4521,共3页 Chongqing medicine
基金 贵州省科学技术基金资助项目(黔科合J字LKZ[2011]40号)
关键词 基因缺失 RHOA 乳腺肿瘤 免疫组织化学 淋巴道转移 gene deletion RhoA breast noplasms immunochemistry lymphatic metastasis
  • 相关文献

参考文献4

二级参考文献54

  • 1于月成,辛晓燕,吴维光,李红梅,李奇灵.Rho和ROCK蛋白在上皮性卵巢癌中的表达及临床意义[J].现代肿瘤医学,2006,14(4):461-464. 被引量:24
  • 2王启俊,祝伟星,邢秀梅.北京城区女性乳腺癌发病死亡和生存情况20年监测分析[J].中华肿瘤杂志,2006,28(3):208-210. 被引量:81
  • 3杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 4陈建国,朱健,张永辉.启东市1972~2000年主要恶性肿瘤生存率分析[J].中国肿瘤,2006,15(9):575-578. 被引量:34
  • 5Yuan BZ, Miller M J, Keck CL, et al. characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1)homologous to rat RhoGAP [J]. Cancer Res, 1998, 58: 2196-9.
  • 6Liao YC, Lo SH. Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver[J]. Int J Biochem Cell Biol, 2008, 40 (5): 843-7.
  • 7Yang X, Popescu NC, Zimonjic DB. DLC1 interaction with S100A10 mediates inhibition of In vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP- independent mechanism[J]. Cancer Res, 2011, 71(8): 2916-25.
  • 8Heering J, Erlmann P, Olayioye MA. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration[J-. Exp Cell Res, 2009, 315(15): 2505-14.
  • 9Low JS, Tao Q, Ng KM, et al. A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors [J]. Oncogene, 2011, 30(16): 1923-35.
  • 10Hall EH, Daugherty AE, Choi CK, et al. Tensinl requires protein phosphatase-lalpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion [J]. J Biol Chem, 2009, 284 (50): 34713-22.

共引文献868

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部